Hao, CA
Alvin Hao, Cerritos, CA US
Patent application number | Description | Published |
---|---|---|
20130038216 | REMOTE CONTROLLED ELECTRONIC BALLAST WITH DIGITAL DISPLAY - The present invention is a remote controlled electronic ballast, which preferably includes: a ballast, counter, scheduling timer, remote control, digital display screen, ignition control, and diagnostic circuitry. The counter preferably tracks the total hours in which the ballast has operated. This count may be displayed, if requested on the digital display screen. The scheduling timer preferably triggers the ballast to ignite and/or drive the lamp at various time intervals. The remote control preferably allows the user to wirelessly: (1) set the wattage output; (2) control the timer settings; (3) display the count; and/or (4) turn the lamp on or off. The display preferably provides visual information of the ballast's setting. The ignition control preferably allows the user to start up multiple lamps in a series to prevent the breaker from being tripped. The diagnostic and sensory circuitry preferably performs a pre-ignition check for fault conditions. | 02-14-2013 |
Christine Hao, Palo Alto, CA US
Patent application number | Description | Published |
---|---|---|
20110225266 | STORAGE SYSTEMS AND METHODS - Systems and methods for extent reference count updates are presented. In one embodiment; a reference count update method includes: receiving a plurality of data files associated with various modalities; performing an analysis on the data files including examining an impact of the plurality of data files on storage based upon a type of the modality; and forwarding resulting analysis information for presentation in a convenient user interface, including an indication of the impact of the plurality of data files on the storage based upon the type of the modality. In one embodiment the analysis includes resource consumption analysis of the storage associated with the type of modality. The analysis can include a cost analysis of the storage associated with the type of modality. The storage can be included in a cloud environment. | 09-15-2011 |
Eric Hao, Cupertino, CA US
Patent application number | Description | Published |
---|---|---|
20090254734 | Partial Load/Store Forward Prediction - In one embodiment, a processor comprises a prediction circuit and another circuit coupled to the prediction circuit. The prediction circuit is configured to predict whether or not a first load instruction will experience a partial store to load forward (PSTLF) event during execution. A PSTLF event occurs if a plurality of bytes, accessed responsive to the first load instruction during execution, include at least a first byte updated responsive to a previous uncommitted store operation and also include at least a second byte not updated responsive to the previous uncommitted store operation. Coupled to receive the first load instruction, the circuit is configured to generate one or more load operations responsive to the first load instruction. The load operations are to be executed in the processor to execute the first load instruction, and a number of the load operations is dependent on the prediction by the prediction circuit. | 10-08-2009 |
20100138638 | SYSTEM AND METHOD OF INSTRUCTION MODIFICATION - A method and system of instruction modification. A first machine language instruction, which may comprise a plurality of discrete instructions, is fetched. Responsive to a trigger pattern in the first machine language instruction, a segment of the first machine language instruction is modified. Information can be substituted into the segment based on specifics outlined in the trigger pattern. Alternatively, information can be combined with the segment via logical and/or arithmetic operations. Modification of the segment produces a second machine language instruction that is executed by units of the processor. In one embodiment, information may be taken from a queue and used to replace data from the segment. How information is taken from the queue and how the information so taken is used to replace fields of the segment are defined by the trigger pattern. | 06-03-2010 |
20110238961 | SYSTEM AND METHOD OF INSTRUCTION MODIFICATION - A method and system of instruction modification. A first machine language instruction, which may comprise a plurality of discrete instructions, is fetched. Responsive to a trigger pattern in the first machine language instruction, a segment of the first machine language instruction is modified. Information can be substituted into the segment based on specifics outlined in the trigger pattern. Alternatively, information can be combined with the segment via logical and/or arithmetic operations. Modification of the segment produces a second machine language instruction that is executed by units of the processor. In one embodiment, information may be taken from a queue and used to replace data from the segment. How information is taken from the queue and how the information so taken is used to replace fields of the segment are defined by the trigger pattern. | 09-29-2011 |
20120110392 | MISALIGNMENT PREDICTOR - In one embodiment, a processor comprises a circuit coupled to receive an indication of a memory operation to be executed in the processor. The circuit is configured to predict whether or not the memory operation is misaligned. A number of accesses performed by the processor to execute the memory operation is dependent on whether or not the circuit predicts the memory operation as misaligned. In another embodiment, a misalignment predictor is coupled to receive an indication of a memory operation, and comprises a memory and a control circuit coupled to the memory. The memory is configured to store a plurality of indications of memory operations previously detected as misaligned during execution in a processor. The control circuit is configured to predict whether or not a memory operation is misaligned responsive to a comparison of the received indication and the plurality of indications stored in the memory. | 05-03-2012 |
Fangli Hao, Cupertino, CA US
Patent application number | Description | Published |
---|---|---|
20110259519 | COATING METHOD FOR GAS DELIVERY SYSTEM - A method of coating the inner surfaces of gas passages of a gas delivery system for a plasma process system such as a plasma etching system includes (a) flowing a fluidic precursor of a corrosion-resistant material through the gas passages and depositing a layer of the fluidic precursor to completely coat the inner surfaces of the gas passages; (b) removing excess fluidic precursor from the inner surfaces; (c) curing the deposited layer of the fluidic precursor to form a corrosion-resistant material coating. | 10-27-2011 |
20130100278 | AUTOMATED BUBBLE DETECTION APPARATUS AND METHOD - An automated hydrogen bubble detection apparatus includes a horizontal support surface on which a test coupon can be supported, a transparent tube having an open top and an open bottom and operable to contain a test solution when positioned on a test coupon, a camera arranged to view a test solution in the transparent tube, and a controller in communication with the camera and effective to operate the camera such that at least one video segment is recorded by the camera and analyzed to detect first bubble and continuous bubble generation. A method of evaluating corrosion resistance of coatings on aluminum and steel in acidic solution is also included. | 04-25-2013 |
20140366968 | COATING METHOD FOR GAS DELIVERY SYSTEM - A gas delivery system for a plasma process system such as a plasma etching system wherein inner surfaces of gas passages are coated with a corrosion-resistant material coating formed by curing a layer of fluidic precursor deposited on the inner surfaces. The coating can be formed by (a) flowing a fluidic precursor of a corrosion-resistant material through the gas passages and depositing a layer of the fluidic precursor to completely coat the inner surfaces of the gas passages; (b) removing excess fluidic precursor from the inner surfaces; (c) curing the deposited layer of the fluidic precursor to form a corrosion-resistant material coating. | 12-18-2014 |
Fangli J. Hao, Cupertino, CA US
Patent application number | Description | Published |
---|---|---|
20100187777 | PIN LIFTING SYSTEM - An aspect of the present invention is drawn to a device for use with an electrostatic chuck having a top surface and a bottom surface, the top surface being separated from the bottom surface by a width, the electrostatic chuck additionally having a hole therein, the hole having a first width at the top surface and having a second width at the bottom surface, the first width being less than the second width, the top surface being capable of having wafer disposed thereon. The device includes a pin, a shaft, a neck portion and an outer housing portion. The pin has a pin width less than the first width. The shaft has a pin-holding portion, an end portion and a central portion disposed between the pin-holding portion and the end portion. The central portion has a first bearing portion. The outer housing portion has a first end and a second end and includes a second bearing portion. The shaft is disposed within the outer housing portion and is moveable relative to the outer housing portion. The neck portion is disposed at the first end. The second bearing portion is stationary relative to the neck portion. The first bearing portion is movable relative to the second bearing portion. | 07-29-2010 |
Jennifer Fangli Hao, Cupertino, CA US
Patent application number | Description | Published |
---|---|---|
20120070996 | POLAR REGIONS FOR ELECTROSTATIC DE-CHUCKING WITH LIFT PINS - An apparatus for electrostatic chucking and dechucking of a semiconductor wafer includes an electrostatic chuck with a number of zones. Each zone includes one or more polar regions around a lift pin that contacts a bottom surface of the semiconductor wafer. The apparatus also includes one or more controllers that control the lift pins and one or more controllers that control the polar regions. The controller for the lift pins receives data from one or more sensors and uses the data to adjust the upward force of the lift pins. Likewise, the controller for the polar regions receives data from the sensors and uses the data to adjust the voltage in the polar regions. | 03-22-2012 |
Jianbin Hao, San Jose, CA US
Patent application number | Description | Published |
---|---|---|
20080239082 | HDMI format video pattern and audio frequencies generator for field test and built-in self test - A versatile video pattern and audio pattern generation module, that can be integrated onto a video integrated circuit (IC) to generate functional video test input data, in HDMI format, for gray bars, color bars and moving bar data patterns, and to further generate single-tone audio signals, is disclosed. This video signal generator can be made part of the built-in-self test (BIST) to allow simplified testing of the IC. The signals generated can be used to test the video and audio functionality, as well as enabling a system to be demonstrated in the field. The output of the generator during the demonstration can be displayed using any suitable video display enabling simplified demonstration set-up. These video and audio signals can bemused as a diagnostic tool by the consumer and also for debugging the IC and system as may be necessary. | 10-02-2008 |
20080320324 | Data recovery (CDR) architecture using interpolator and timing loop module - The present invention provides a method and mechanism for data recovery with phase synchronized clock using interpolator and timing loop module and a data latching circuit. The interpolator can be considered as a programmable delay circuit with a specified delay resolution over the clock period. | 12-25-2008 |
Jin Hao, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20120133377 | TRANSMISSION LINE BASED ELECTRIC FENCE WITH INTRUSION LOCATION ABILITY - An electric security fence. An electric signal generator generates an initial electric signal. The generated initial electric signal is transmitted through a transmission line. The transmission line will generate a reflected electric signal when the transmission line is disturbed by the presence of a human or animal at a disturbance area. A receiver receives the reflected electric signal and forwards it to a signal processing unit. The signal processing unit calculates the location of the disturbance area after receiving the reflected electric signal. In one preferred embodiment, the signal processing unit calculates the location of the disturbance area by determining the amount of time required for the reflected signal to travel from the disturbance area. In another preferred embodiment, the signal processing unit calculates the location of the disturbance area by determining the frequency difference between an initial Frequency Modulated Continuous Wave signal and the reflected Frequency Modulated Continuous Wave signal. In another preferred embodiment the transmission wire is utilized to send coded communication signals and distance information back to a base station for monitoring and information transmission. | 05-31-2012 |
20120181258 | Apparatus and methods for transmission line based electric fence insulation - Apparatus and methods for wire insulation in transmission line based electric fence are described in this invention. An insulator holds a wire pair that form the transmission line in its wire clamps. The insulator has a rain shed that sheds the wire clamps from getting wet by rain water. The insulator also has a pair of rain water divert guides that guide rain water accumulated on the wire to flow to the guide instead of to the wire clamps. This invention also describes a wire heating method that uses electric current to heat the fence wires such that the wire/wire clamp contact point will be kept dry and ice, snow accumulated on fence wires will be melted. Performance of the transmission line based electric fence can thus be greatly improved in advert weather conditions. | 07-19-2012 |
20120223282 | In Line Signal Repeaters for Transmission Line Based Electric Fences - An electric repeater for use in transmission line based electric fences. The electric repeater comprises a forward amplifier, a backward amplifier, a quad pole quad throw signal switch, and a monostable circuit. The short forward electric pulse in the transmission line is amplified by the forward amplifier, and the amplified electric pulse trigger the monostable circuit. The monostable circuit then outputs a n electric pulse with predetermined width. This electric pulse operates the quad pole quad throw signal switch such that the wire pair of the transmission line is connected to the backward amplifier and disconnected from the forward amplifier as soon as the forward electric pulse has passed through the forward amplifier. DC electric power is supplied to the forward amplifier and backward amplifier by the transmission line metal wire pair, and two pairs of capacitors are used to block this DC electric power from entering the input and output of the forward and backward amplifiers. A low pass filter is inserted in each of the transmission line metal wires so that short electric pulse is forced to go through the forward and backward amplifiers while DC electric power may flow through these low pass filters to power repeaters further down the transmission line. A section of the transmission line immediately after the repeater is hidden in the supporting post to eliminate the dead zone in the transmission line based electric fence. | 09-06-2012 |
20130271113 | Diffractive MEMS based fiber optic AC electric field strength/voltage sensor for applications in high voltage environments - A fiber optic AC electric field or voltage sensing system is described for applications in high voltage environment, particularly, in the vicinity of a power line. The system is based on diffractive MEMS device. A condenser antenna positioned in the electric field feeds a voltage signal to the diffractive MEMS device, which then modulates the light signal passing through it. In the optical receiver, the electric filed strength is measured from the received optical signal. | 10-17-2013 |
20130335730 | Drift compensated optical current and voltage sensors with an electric reference channel - An electric reference signal channel is added to the main signal in a hybrid optical current sensor or voltage sensor. This reference signal has a frequency that is outside the main signal's frequency band. A summing integrator of a summing amplifier combines the reference signal with the main signal, and the combined signals drives an electro-optic device. This electro-optic device drives the input CW optical signal. An optical receiver converts the received optical signal into electric signal. Two band pass filters separate the main signal and the reference signal into their respective paths. A signal processing unit calculates the ratio of the main signal to the reference signal. Therefore, drifts in the optical source and all the optical path are factored out. | 12-19-2013 |
20140070792 | Handheld fiber optic current and voltage monitor for high voltage applications - A handheld fiber optic current and voltage monitor for applications in high voltage environment. A light source generates constant optical signal that is split by a fiber optic splitter into two paths. One path feeds a DMEMS based current sensor that is driven by a current to voltage conversion device that converts the current in a conductor into a voltage. The other path goes to a DMEMS based electric field sensor driven by a condenser antenna that converts the electric field near a high voltage power line conductor into a voltage. The output optical signals from the current sensor and the electric field sensor are received by respective optical receivers and converted into electric signals. A signal processing unit processes the signals, and a display screen displays the results. All these are mounted on a plastic mast for handheld operation. | 03-13-2014 |
20140354973 | Structural health monitoring method and apparatus based on optical fiber bend loss measurement - A fiber optic strain sensor, an optical pulse generator generates an initial optical pulse, and launches it into an optical fiber-optical strain probe chain through an optical circulator. The scattered optical power in the optical fiber and optical strain probe chain is sent to an optical receiver, also via the optical circulator. The optical strain probes are attached to a structure whose strain is to be measured. Strain in the structure causes the fiber bend loss to change in the strain probe, and causes the scattered optical power received by the optical receiver to change accordingly. From the change of the output of the optical receiver and the time required for the scattered optical power to travel from the probe, the strain at each of the probes is calculated. | 12-04-2014 |
Jin Hao, San Deigo, CA US
Patent application number | Description | Published |
---|---|---|
20120133378 | TRANSMISSION LINE BASED ELECTRIC FENCE WITH INTRUSION LOCATION ABILITY - An electric security fence. An electric signal generator generates an initial electric signal. The generated initial electric signal is transmitted through a transmission line. The transmission line will generate a reflected electric signal when the transmission line is disturbed by the presence of a human or animal at a disturbance area. A receiver receives the reflected electric signal and forwards it to a signal processing unit. The signal processing unit calculates the location of the disturbance area after receiving the reflected electric signal. In one preferred embodiment, the signal processing unit calculates the location of the disturbance area by determining the amount of time required for the reflected signal to travel from the disturbance area. In another preferred embodiment, the signal processing unit calculates the location of the disturbance area by determining the frequency difference between an initial Frequency Modulated Continuous Wave signal and the reflected Frequency Modulated Continuous Wave signal. In another preferred embodiment the transmission wire is utilized to send coded communication signals and distance information back to a base station for monitoring and information transmission. | 05-31-2012 |
Junmin Hao, Cupertino, CA US
Patent application number | Description | Published |
---|---|---|
20100223627 | Application Tune Manifests and Tune State Recovery - In accordance with one or more aspects, a request to run an application is received. The application has an associated tune manifest that identifies one or more resources that the application may use. The tune manifest is compared to a device resource record, and a check is made, based at least in part on the comparing, whether the one or more resources identified in the tune manifest can be satisfied by the device. If the one or more resources identified in the tune manifest can be satisfied by the device, then the application is run; otherwise, a notification of a conflict between the application and the device is presented. Additionally, when the application exits, a device tune state that identifies a content source to which the device was tuned prior to running the application can be retrieved and the device restored to this device tune state. | 09-02-2010 |
20100299620 | LARGE SETS OF DATA - This document describes tools that enable a computing device to retrieve large data in smaller blocks. The tools also allow the computing device to receive and display data that does not include display formatting information through the use of templates. | 11-25-2010 |
20110119330 | SELECTIVE CONTENT LOADING BASED ON COMPLEXITY - Selective content loading based on complexity is provided by a method of selectively loading content which includes receiving markup data at a client computing device and determining a markup weight for the markup data at the client computing device. The method further includes determining if the markup weight is less than a threshold value at the client computing device. The method further includes, if the markup weight is less than the threshold value, loading the markup data at the client computing device, and if the markup weight is not less than the threshold value, not allowing the markup data to load at the client computing device. | 05-19-2011 |
Junmin Hao, Sunnyvale, CA US
Patent application number | Description | Published |
---|---|---|
20110209206 | ACCESS RESTRICTION FOR COMPUTING CONTENT - Access restriction for computing content is provided by operating a computing device with a first profile, recognizing an attempt to log off of the first profile, and requesting a user to supply a log off credential. If the log off credential is not correct, the computing device continues to operate with the first profile, and if the log off credential is correct, the computing device operates without the first profile. | 08-25-2011 |
Li Hao, Cupertino, CA US
Patent application number | Description | Published |
---|---|---|
20090066820 | FILTERING OPTIMIZATION VIA IMPLICIT BAYER GRID SUBSAMPLING - Methods, systems, and apparatuses for filtering captured image data are provided. An array of pixel data values corresponding to a captured image is received. The pixel data values in the received array are pixel data values of a first color of the captured image. A filter function is performed on a portion of the pixel data values of the array that are located in Bayer pattern pixel locations of the array for the first color. Subsequent arrays of pixel data values corresponding to further colors of the captured image may be received and filtered in a similar manner. Furthermore, further captured images in a video stream may be received and filtered in a similar manner, to generate a stream of filtered video images. | 03-12-2009 |
20090080770 | IMAGE PIXEL SUBSAMPLING TO REDUCE A NUMBER OF PIXEL CALCULATIONS - Methods, systems, and apparatuses for processing captured image data are described. A first array of pixel data values corresponding to a captured image is received. The first array is segmented into a plurality of N by M array portions. A subsample pattern is selected for each N by M array portion of the plurality of N by M array portions from a plurality of subsample patterns so that each N by M array portion has a corresponding selected subsample pattern. The subsample patterns may be selected in a random fashion, or other fashion, to avoid noise patterns in a spatial domain (same image frame) and/or in a time domain (across multiple image frames). Each N by M array portion is subsampled according to the corresponding selected subsample pattern to generate a second array of filtered pixel data values. The second array of filtered pixel data values corresponds to a down-sized version of the captured image. This process may be performed on data of multiple color channels corresponding to the captured image, and on data corresponding to multiple captured image frames in a video stream. | 03-26-2009 |
20090097771 | IN-PLACE AVERAGING OF PACKED PIXEL DATA - Methods, systems, and apparatuses for averaging data in packed format are provided. The data may be image data, such as data words containing color-specific data portions representative of pixels of a captured image. A first data word containing first image data is received. A second data word containing second image data is received. A logical AND of the first data word and the second data word is performed to generate a third data word. A logical exclusive OR (XOR) of the first data word and the second data word is performed to generate a fourth data word. A right shift of the fourth data word is performed. The third data word and the right shifted fourth data word are summed to generate a fifth data word that is an average of the first and second data words. | 04-16-2009 |
20100231797 | VIDEO TRANSITION ASSISTED ERROR RECOVERY FOR VIDEO DATA DELIVERY - Techniques for video data delivery are provided. A first data stream is received that includes a plurality of video data frames. At least one corrupted video data frame is detected in the first data stream. At least one replacement video data frame is generated for the corrupted video data frame(s) based at least on a non-corrupted video data frame received in the first data stream prior to the corrupted video data frame(s). The replacement video data frame(s) include a modified form of the non-corrupted video data frame, and are configured to provide a smooth scene transition from the non-corrupted video data frame. The corrupted video data frame(s) are replaced in the first data stream with the generated replacement video data frame(s) to generate a second data stream. | 09-16-2010 |
Lin-Yih Hao, Santa Clara, CA US
Patent application number | Description | Published |
---|---|---|
20130170424 | SELECTIVELY MULTIPLEXING COMMUNICATION STREAMS - In an embodiment, a network device obtains a plurality of data packets that are each associated with one of a plurality of different streams, wherein each of the plurality of obtained data packets includes a header portion with stream-specific routing information. The network device strips the stream-specific routing information from the plurality of obtained data packets to produce a plurality of stream-specific payload portions, which are merged into a shared payload portion of a stream-multiplexed data packet that includes common routing information for the plurality of streams in a common header portion. The network device transmits the stream-multiplexed packet to a target device, and the target device determines whether any of the plurality of different streams are relevant to the target UE based on stream-mapping information contained in the stream-multiplexed packet, and selectively decodes and processes the stream-specific payload portions corresponding based on the determination. | 07-04-2013 |
20130170450 | WIRELESS BROADCAST/MULTICAST SERVICE CAPACITY OVER DIFFERENT LINK BUDGETS AND OVERLAY NETWORKS - In an embodiment, an application server determines to transmit a first data stream in a first multicasting area, a second data stream in a second multicasting area and both data streams in a third multicasting area that overlaps with the second multicasting area (e.g., at a border region between the first and second multicasting areas). The application server sends the first data stream to a multicast network management node for transmission in the first and third multicasting areas. The application server sends the first and second data streams to a multiplex stream multiplexer that multiplexes the two data streams into a single higher-rate multiplexed multicast stream with packets that include payloads data for both the first and second data streams. The multiplexed multicast stream is delivered to the third multicasting area for transmission to at least one target UE. | 07-04-2013 |
Minshen Hao, Los Angeles, CA US
Patent application number | Description | Published |
---|---|---|
20130332120 | SYSTEM AND METHOD FOR AGGREGATING RESERVOIR CONNECTIVITIES - Described herein is a method of predicting production rates of one or more wells configured to extract petroleum from a petroleum reservoir, the production rates affected by one or more injectors configured to inject water into the petroleum reservoir, the method comprising: calculating a relationship parameter, using a plurality of models, for each of the one or more wells and an associated one of the one or more injectors; predicting future values of the relationship parameter calculated using the plurality of model; calculating a weighted aggregate of the future values of the relationship parameter, wherein weights for the future values are those that minimize a prediction error; predicting the production rates using the a weighted aggregate. | 12-12-2013 |
Rui Hao, Los Angeles, CA US
Patent application number | Description | Published |
---|---|---|
20100184112 | NOVEL AFFINITY BASED METHOD FOR DRUG TARGET IDENTIFICATION - Drug affinity responsive target stability (DARTS) is a novel method of drug target ID with several significant advantages over current techniques. In certain embodiments the method involves contacting a sample comprising one or more protein target(s) with a test agent to form a sample/test agent mixture; contacting the mixture with a protease; and identifying a protein or protein fragment that is protected from proteolysis, wherein the protection from proteolysis is an indicator that the protein or protein fragment binds to or interacts with the test agent. | 07-22-2010 |
Ruiying Hao, San Jose, CA US
Patent application number | Description | Published |
---|---|---|
20150040979 | Silicon Wafers with p-n Junctions by Epitaxial Deposition and Devices Fabricated Therefrom - High efficiency silicon solar cells, including IBC cells, may be formed from lightly doped p-n sandwich structures fabricated in-situ by epitaxial growth. For example, the solar cell may comprise: an n-type silicon layer greater than or equal to 20 microns thick, with a dopant concentration between 1E15/cm | 02-12-2015 |
Shouwei Hao, Gilroy, CA US
Patent application number | Description | Published |
---|---|---|
20140272528 | MANUFACTURING TECHNIQUES USING BINDER COATINGS IN THREE-DIMENSIONAL STACKED-CELL BATTERIES - The disclosed embodiments relate to the manufacture of a battery cell. The battery cell includes a first set of layers including a cathode with an active coating, a separator, and an anode with an active coating. The separator may include a ceramic coating and a binder coating over the ceramic coating. During manufacturing of the battery cell, the layers are stacked, and the binder coating is used to laminate the first set of layers within the first sub-cell by applying at least one of pressure and temperature to the first set of layers. | 09-18-2014 |
20140272529 | MANUFACTURING TECHNIQUES USING UNIFORM PRESSURE TO FORM THREE-DIMENSIONAL STACKED-CELL BATTERIES - The disclosed embodiments relate to the manufacture of a battery cell. The battery cell includes a first set of layers including a cathode with an active coating, a separator, and an anode with an active coating. The separator may include a ceramic coating and a binder coating over the ceramic coating. During manufacturing of the battery cell, the layers are stacked, and the binder coating is used to laminate the first set of layers within the first sub-cell by applying at least one of pressure and temperature to the first set of layers. In addition, uniform pressure is applied to the cell stack to laminate the first and second sets of layers. | 09-18-2014 |
20140272543 | MANUFACTURING TECHNIQUES USING FIDUCIALS IN THREE-DIMENSIONAL STACKED-CELL BATTERIES - The disclosed embodiments relate to the manufacture of a battery cell. The battery cell includes a first set of layers including a cathode with an active coating, a separator, and an anode with an active coating. The separator may include a ceramic coating and a binder coating over the ceramic coating. During manufacturing of the battery cell, the layers are stacked, and the binder coating is used to laminate the first set of layers within the first sub-cell by applying at least one of pressure and temperature to the first set of layers. One or more fiducials are also disposed on each electrode from a set of electrodes for the battery cell and/or a fixture for the electrodes. The one or more fiducials may be used to align the electrodes during stacking of the set of electrodes. | 09-18-2014 |
Su Hao, Irvine, CA US
Patent application number | Description | Published |
---|---|---|
20140318043 | Class of Bearings to Protect Structures from Earthquake and Other Similar Hazards - A class of bearings, each of them can be used as a connector to connect two parts in a structural system and as a supporter to transfer loads from one part to another, for examples, gravity of a superstructure to a substructure in a bridge or a building, or that of a machine to its foundation. While performing load transmission, it is able to reduce the transmission of transient vibrations between connected two structural parts and preserve the integrity of entire structural system; for examples, to protect a bridge's structural integrity when either an earthquake strikes its pier and foundation or a tsunami hits its superstructure or both occur simultaneously. | 10-30-2014 |
Wen Hao, Industry, CA US
Patent application number | Description | Published |
---|---|---|
20100043235 | UTILITY KNIFE WITH EXTENDED TRAVEL CARRIAGE - A utility knife has a handle generally defining a handle axis and a remote end provided with an opening. A carriage is slidably mounted within the handle for selective movements through the opening between a retracted position in which the carriage is substantially fully received within the handle and a fully extended position in which the carriage is fully extended through the opening to increase the effective length of said handle by a distance Δl. A blade mounted on the carriage shares the movements of the carriage and has an operative portion that can fully penetrate a work to be cut when the handle axis is inclined at an angle α relative to a surface of the work. A finger of a user most proximate to the work surface is positionable a distance h above the work surface during normal use of the utility knife, Δl and α being selected so that the distance Δl is generally greater that 1.0 inch and the angle α is equal to at least 35°. | 02-25-2010 |
Wen Hao, City Of Industry, CA US
Patent application number | Description | Published |
---|---|---|
20090271951 | HAND GRIPS WITH GEL STRESS RELIEVING INSERTS - Hand grip for hand tools and the like contains a plurality of elastomeric compositions to protect the users hand during use. As proposed a plurality of gel inserts are provided with varying degrees of hardness and density to provide an improved ergonomic design while insuring the integrity of the handle. | 11-05-2009 |
20100281696 | SELF LOADING UTILITY KNIFE - A self-loading utility knife including an elongate handle having an internal chamber defining an axis and at one end is flat aperture for the passage of an active blade. The flat aperture defines a cutting plane extending through said handle along the axis. A blade-holder is slidably mounted in the chamber for movements in directions along the axis and is adapted to secure a single active blade for movement through the aperture when the blade holder is in the extended position. A blade-holder release button is coupled to the blade holder and is slidingly movable relative to the handle to move blade holder between retracted and extended positions. The handle has a blade compartment which is open to the chamber and can receive a stack of spare blades when a cover to the compartment is opened and blades can be shifted transversely relative to the axis into the chamber. The blade holder is provided with a recess having a depth no greater than the thickness of one blade to allow at least a portion of a single blade to be received in a retaining relationship within the recess to cause an end-most blade in the stack to be received within said recess to follow the movements of the blade holder. A spring biases the blades in the blade compartment inwardly in the direction of the blade holder. A blade releasing disc on the blade holder selectively locks a blade to the blade holder when the blade holder is in the extended position. The blade holder only receives a single blade within the recess. A belt clip s provided on the compartment cover. | 11-11-2010 |
20120017443 | SIDE BLADE LOCK AND RELEASE MECHANISM FOR USE WITH A KNIFE - A knife is provided. The knife comprises a handle and a blade configured to pivot with respect to the handle between an open position wherein a cutting edge of the blade is exposed and a closed position wherein the cutting edge of the blade is disposed within the handle, the blade including an abutting surface. The knife may further comprise a locking assembly configured to releasably lock the blade in the open position, the locking assembly comprising a biased, rotatable member having a canted surface for engaging a corresponding surface on the blade, wherein the canted surface and the corresponding surface are configured to secure the blade relative to the handle in the open position. | 01-26-2012 |
Wuyang Hao, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20110238203 | Method and Apparatus to Provide a Clock Signal to a Charge Pump - A method and apparatus for providing a clock signal to a charge pump is disclosed. In a particular embodiment, the method includes providing a first clock signal to a first charge pump unit of a charge pump. The method further includes providing a second clock signal to a second charge pump unit of the charge pump. A low-to-high transition of the first clock signal occurs substantially concurrently with a high-to-low transition of the second clock signal. Only one clock signal may be at a logic high voltage level at any given time. | 09-29-2011 |
20110280065 | Write Energy Conservation In Memory - A method writes data to a resistive memory, such as spin torque transfer magnetic random access memory (STT-MRAM). The method writes received bits of data to a memory cell array, in response to a first write signal. The method also reads stored data from the memory cell array, after the first write signal is generated, and then compares the stored data with the received bits of data to determine whether each of the received bits of data was written to the memory. In response to a second write signal, received bits of data determined not to have been written during the first write signal, are written. | 11-17-2011 |
20120033490 | Generating a Non-Reversible State at a Bitcell Having a First Magnetic Tunnel Junction and a Second Magnetic Tunnel Junction - A method of generating a non-reversible state at a bitcell having a first magnetic tunnel junction (MTJ) and a second MTJ includes applying a program voltage to the first MTJ of the bitcell without applying the program voltage to the second MTJ of the bitcell. A memory device includes a bitcell having a first MTJ and a second MTJ and programming circuitry configured to generate a non-reversible state at the bitcell by applying a program signal to a selected one of the first MTJ and the second MTJ of the bitcell. | 02-09-2012 |
20130028010 | Fast MTJ Switching Write Circuit For MRAM Array - A transmission gate is arranged between a current source and a resistive memory element, a PMOS gate of the transmission gate has no source loading effect and a write current passes from the current source, and in a first direction through the resistive memory element, setting the resistive memory element to a magnetization state. An NMOS gate of the of the transmission gate has no source loading effect and another write current, passes through the resistive memory element, in a second direction opposite the first direction, and through the transmission gate, setting the resistive memory element to an opposite magnetization state. | 01-31-2013 |
20130120050 | LOW-POWER VOLTAGE REFERENCE CIRCUIT - Methods and apparatus for a providing temperature-compensated reference voltage are provided. In an example, a temperature-compensated voltage reference circuit includes a current mirror portion and a temperature-compensated output portion coupled to the current mirror portion. The temperature-compensated output portion comprises a very low threshold voltage (Vt) transistor coupled in series with a negative temperature coefficient transistor. The output portion can further include a positive temperature coefficient element coupled in series with the very low Vt transistor. The positive temperature coefficient element can be an adjustable resistive element. The output portion can further include an output transistor having a gate coupled to the current mirror portion and coupled between a supply voltage and the positive temperature coefficient element. The very low Vt transistor can be a substantially zero Vt n-channel metal-oxide-semiconductor (NMOS) transistor, and can be coupled in a diode configuration. | 05-16-2013 |
Wuyang Hao, San Jose, CA US
Patent application number | Description | Published |
---|---|---|
20140010006 | NON-REVERSIBLE STATE AT A BITCELL HAVING A FIRST MAGNETIC TUNNEL JUNCTION AND A SECOND MAGNETIC TUNNEL JUNCTION - A memory device includes a magnetic tunnel junction (MTJ) bitcell. The MTJ bitcell includes a first MTJ and a second MTJ. The memory device further includes programming circuitry configured to generate a non-reversible state at the bitcell by applying a program signal to a selected one of the first MTJ and the second MTJ of the bitcell. The non-reversible state corresponds to a value of the MTJ bitcell that is determined by comparing a first value read at the first MTJ and a second value read at the second MTJ. | 01-09-2014 |
Wuyang Hao, Santa Clara, CA US
Patent application number | Description | Published |
---|---|---|
20140119097 | RESISTANCE-BASED MEMORY HAVING TWO-DIODE ACCESS DEVICE - A resistance-based memory includes a two-diode access device. In a particular embodiment, a method includes biasing a bit line with a first voltage. The method further includes biasing the sense line with a second voltage. Biasing the bit line and biasing the sense line generates a current through a resistance-based memory element and through one of a first diode and a second diode. A cathode of the first diode is coupled to the bit line and an anode of the second diode is coupled to the sense line. | 05-01-2014 |
20150279451 | EDGE-TRIGGERED PULSE LATCH - A pulse latch is provided that latches a ground signal responsive to decoded signal carried on a decoded signal node. The pulse latch includes a reset logic circuit that controls a switch coupled between the decoded signal node and ground such that when the switch is turned on by the reset logic circuit, the decoded signal node is grounded. The reset of the decoded signal node by the reset logic circuit is responsive to a ground signal. The ground signal is generated so as to be responsive to a clock edge. Thus, the reset of the decoded signal node is also responsive to the clock edge. | 10-01-2015 |
Xianghong Hao, Foster City, CA US
Patent application number | Description | Published |
---|---|---|
20100184587 | PALLADIUM-GOLD CATALYST SYNTHESIS - A supported palladium-gold catalyst is produced under mild conditions using a commonly available base, such as sodium hydroxide (NaOH) or sodium carbonate (Na | 07-22-2010 |
20110143921 | ENGINE EXHAUST CATALYSTS CONTAINING COPPER-CERIA - An emission control catalyst includes copper-ceria to boost low temperature CO oxidation performance, generate exothermic heat during the process, and reduce HC and NO | 06-16-2011 |
20130331258 | PALLADIUM-GOLD CATALYST SYNTHESIS - A supported palladium-gold catalyst is produced under mild conditions using a commonly available base, such as sodium hydroxide (NaOH) or sodium carbonate (Na | 12-12-2013 |
Xiaojie Hao, Milpitas, CA US
Patent application number | Description | Published |
---|---|---|
20150287908 | MAGNETIC RANDOM ACCESS MEMORY WITH PERPENDICULAR ENHANCEMENT LAYER - The present invention is directed to an MTJ memory element including a magnetic free layer structure which comprises one or more magnetic free layers that have a same variable magnetization direction substantially perpendicular to layer planes thereof; an insulating tunnel junction layer formed adjacent to the magnetic free layer structure; a magnetic reference layer structure comprising a first magnetic reference layer formed adjacent to the insulating tunnel junction layer and a second magnetic reference layer separated therefrom by a perpendicular enhancement layer with the first and second magnetic reference layers having a first fixed magnetization direction substantially perpendicular to layer planes thereof; an anti-ferromagnetic coupling layer formed adjacent to the second magnetic reference layer opposite the perpendicular enhancement layer; and a magnetic fixed layer comprising first and second magnetic fixed sublayers with the second magnetic fixed sublayer formed adjacent to the anti-ferromagnetic coupling layer opposite the second magnetic reference layer. | 10-08-2015 |
Xiaolin Hao, Foster City, CA US
Patent application number | Description | Published |
---|---|---|
20090023761 | Heterocyclic compounds and their uses - Substituted bicyclic heteroaryls and compositions containing them, for the treatment of general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, including but not restricted to autoimmune diseases such as systemic lupus erythematosis (SLE), myestenia gravis, rheumatoid arthritis, acute disseminated encephalomyelitis, idiopathic thrombocytopenic purpura, multiples sclerosis, Sjoegren's syndrome and autoimmune hemolytic anemia, allergic conditions including all forms of hypersensitivity, The present invention also enables methods for treating cancers that are mediated, dependent on or associated with p110δ activity, including but not restricted to leukemias, such as Acute Myeloid leukaemia (AML) Myelo-dysplastic syndrome (MDS) myelo-proliferative diseases (MPD) Chronic Myeloid Leukemia (CML) T-cell Acute Lymphoblastic leukaemia (T-ALL) B-cell Acute Lymphoblastic leukaemia (B-ALL) Non Hodgkins Lymphoma (NHL) B-cell lymphoma and solid tumors, such as breast cancer. | 01-22-2009 |
20090030002 | Heterocyclic compounds and their uses - Substituted bicyclic heteroaryls and compositions containing them, for the treatment of general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, including but not restricted to autoimmune diseases such as systemic lupus erythematosis (SLE), myestenia gravis, rheumatoid arthritis, acute disseminated encephalomyelitis, idiopathic thrombocytopenic purpura, multiples sclerosis, Sjoegren's syndrome and autoimmune hemolytic anemia, allergic conditions including all forms of hypersensitivity, The present invention also enables methods for treating cancers that are mediated, dependent on or associated with p110δ activity, including but not restricted to leukemias, such as Acute Myeloid leukaemia (AML) Myelodysplastic syndrome (MDS) myelo-proliferative diseases (MPD) Chronic Myeloid Leukemia (CML) T-cell Acute Lymphoblastic leukaemia (T-ALL) B-cell Acute Lymphoblastic leukaemia (B-ALL) Non Hodgkins Lymphoma (NHL) B-cell lymphoma and solid tumors, such as breast cancer. | 01-29-2009 |
20090137581 | Heterocyclic compounds and their uses - Substituted bicyclic heteroaryls and compositions containing them, for the treatment of general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, including but not restricted to autoimmune diseases such as systemic lupus erythematosis (SLE), myestenia gravis, rheumatoid arthritis, acute disseminated encephalomyelitis, idiopathic thrombocytopenic purpura, multiples sclerosis, Sjoegren's syndrome and autoimmune hemolytic anemia, allergic conditions including all forms of hypersensitivity, The present invention also enables methods for treating cancers that are mediated, dependent on or associated with p110δ activity, including but not restricted to leukemias, such as Acute Myeloid leukaemia (AML) Myelo-dysplastic syndrome (MDS) myelo-proliferative diseases (MPD) Chronic Myeloid Leukemia (CML) T-cell Acute Lymphoblastic leukaemia (T-ALL) B-cell Acute Lymphoblastic leukaemia (B-ALL) Non Hodgkins Lymphoma (NHL) B-cell lymphoma and solid tumors, such as breast cancer. | 05-28-2009 |
20100179177 | HETEROCYCLIC COMPOUNDS AND THEIR USES - Substituted bicyclic heteroaryls and compositions containing them, for the treatment of general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, including but not restricted to autoimmune diseases such as systemic lupus erythematosis (SLE), myestenia gravis, rheumatoid arthritis, acute disseminated encephalomyelitis, idiopathic thrombocytopenic purpura, multiples sclerosis, Sjoegren's syndrome and autoimmune hemolytic anemia, allergic conditions including all forms of hypersensitivity, The present invention also enables methods for treating cancers that are mediated, dependent on or associated with p110δ activity, including but not restricted to leukemias, such as Acute Myeloid leukaemia (AML) Myelo-dysplastic syndrome (MDS) myelo-proliferative diseases (MPD) Chronic Myeloid Leukemia (CML) T-cell Acute Lymphoblastic leukaemia (T-ALL) B-cell Acute Lymphoblastic leukaemia (B-ALL) Non Hodgkins Lymphoma (NHL) B-cell lymphoma and solid tumors, such as breast cancer. | 07-15-2010 |
20100331306 | HETEROCYCLIC COMPOUNDS AND THEIR USES - Substituted bicyclic heteroaryls and compositions containing them, for the treatment of general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, including but not restricted to autoimmune diseases such as systemic lupus erythematosis (SLE), myestenia gravis, rheumatoid arthritis, acute disseminated encephalomyelitis, idiopathic thrombocytopenic purpura, multiples sclerosis, Sjoegren's syndrome and autoimmune hemolytic anemia, allergic conditions including all forms of hypersensitivity. The present invention also enables methods for treating cancers that are mediated, dependent on or associated with p110δ activity, including but not restricted to leukemias, such as Acute Myeloid leukaemia (AML) Myelo-dysplastic syndrome (MDS) myelo-proliferative diseases (MPD) Chronic Myeloid Leukemia (CML) T-cell Acute Lymphoblastic leukaemia (T-ALL) B-cell Acute Lymphoblastic leukaemia (B-ALL) Non Hodgkins Lymphoma (NHL) B-cell lymphoma and solid tumors, such as breast cancer. | 12-30-2010 |
20110152277 | HETEROCYCLIC COMPOUNDS AND THEIR USES - Substituted bicyclic heteroaryls and compositions containing them, for the treatment of general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, including but not restricted to autoimmune diseases such as systemic lupus erythematosis (SLE), myestenia gravis, rheumatoid arthritis, acute disseminated encephalomyelitis, idiopathic thrombocytopenic purpura, multiples sclerosis, Sjoegren's syndrome and autoimmune hemolytic anemia, allergic conditions including all forms of hypersensitivity, The present invention also enables methods for treating cancers that are mediated, dependent on or associated with p110δ activity, including but not restricted to leukemias, such as Acute Myeloid leukaemia (AML) Myelo-dysplastic syndrome (MDS) myelo-proliferative diseases (MPD) Chronic Myeloid Leukemia (CML) T-cell Acute Lymphoblastic leukaemia (T-ALL) B-cell Acute Lymphoblastic leukaemia (B-ALL) Non Hodgkins Lymphoma (NHL) B-cell lymphoma and solid tumors, such as breast cancer. | 06-23-2011 |
20110152296 | HETEROCYCLIC COMPOUNDS AND THEIR USES - Substituted bicyclic heteroaryls and compositions containing them, for the treatment of general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, including but not restricted to autoimmune diseases such as systemic lupus erythematosis (SLE), myestenia gravis, rheumatoid arthritis, acute disseminated encephalomyelitis, idiopathic thrombocytopenic purpura, multiples sclerosis, Sjoegren's syndrome and autoimmune hemolytic anemia, allergic conditions including all forms of hypersensitivity, The present invention also enables methods for treating cancers that are mediated, dependent on or associated with p110δ activity, including but not restricted to leukemias, such as Acute Myeloid leukaemia (AML) Myelo-dysplastic syndrome (MDS) myelo-proliferative diseases (MPD) Chronic Myeloid Leukemia (CML) T-cell Acute Lymphoblastic leukaemia (T-ALL) B-cell Acute Lymphoblastic leukaemia (B-ALL) Non Hodgkins Lymphoma (NHL) B-cell lymphoma and solid tumors, such as breast cancer. | 06-23-2011 |
20110275653 | HETEROCYCLIC COMPOUNDS AND THEIR USES - Substituted bicyclic heteroaryls and compositions containing them, for the treatment of general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, including but not restricted to autoimmune diseases such as systemic lupus erythematosis (SLE), myestenia gravis, rheumatoid arthritis, acute disseminated encephalomyelitis, idiopathic thrombocytopenic purpura, multiples sclerosis, Sjoegren's syndrome and autoimmune hemolytic anemia, allergic conditions including all forms of hypersensitivity, The present invention also enables methods for treating cancers that are mediated, dependent on or associated with p110δ activity, including but not restricted to leukemias, such as Acute Myeloid leukaemia (AML) Myelo-dysplastic syndrome (MDS) myelo-proliferative diseases (MPD) Chronic Myeloid Leukemia (CML) T-cell Acute Lymphoblastic leukaemia (T-ALL) B-cell Acute Lymphoblastic leukaemia (B-ALL) Non Hodgkins Lymphoma (NHL) B-cell lymphoma and solid tumors, such as breast cancer. | 11-10-2011 |
20110275811 | HETEROCYCLIC COMPOUNDS AND THEIR USES - Substituted bicyclic heteroaryls and compositions containing them, for the treatment of general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, including but not restricted to autoimmune diseases such as systemic lupus erythematosis (SLE), myestenia gravis, rheumatoid arthritis, acute disseminated encephalomyelitis, idiopathic thrombocytopenic purpura, multiples sclerosis, Sjoegren's syndrome and autoimmune hemolytic anemia, allergic conditions including all forms of hypersensitivity. The present invention also enables methods for treating cancers that are mediated, dependent on or associated with p110δ activity, including but not restricted to leukemias, such as Acute Myeloid leukaemia (AML) Myelodysplastic syndrome (MDS) myelo-proliferative diseases (MPD) Chronic Myeloid Leukemia (CML) T-cell Acute Lymphoblastic leukaemia (T-ALL) B-cell Acute Lymphoblastic leukaemia (B-ALL) Non Hodgkins Lymphoma (NHL) B-cell lymphoma and solid tumors, such as breast cancer. | 11-10-2011 |
20110281897 | HETEROCYCLIC COMPOUNDS AND THEIR USES - Substituted bicyclic heteroaryls and compositions containing them, for the treatment of general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, including but not restricted to autoimmune diseases such as systemic lupus erythematosis (SLE), myestenia gravis, rheumatoid arthritis, acute disseminated encephalomyelitis, idiopathic thrombocytopenic purpura, multiples sclerosis, Sjoegren's syndrome and autoimmune hemolytic anemia, allergic conditions including all forms of hypersensitivity. The present invention also enables methods for treating cancers that are mediated, dependent on or associated with p110δ activity, including but not restricted to leukemias, such as Acute Myeloid leukaemia (AML) Myelo-dysplastic syndrome (MDS) myelo-proliferative diseases (MPD) Chronic Myeloid Leukemia (CML) T-cell Acute Lymphoblastic leukaemia (T-ALL) B-cell Acute Lymphoblastic leukaemia (B-ALL) Non Hodgkins Lymphoma (NHL) B-cell lymphoma and solid tumors, such as breast cancer. | 11-17-2011 |
20120083502 | HETEROCYCLIC COMPOUNDS AND THEIR USES - Substituted bicyclic heteroaryls and compositions containing them, for the treatment of general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, including but not restricted to autoimmune diseases such as systemic lupus erythematosis (SLE), myestenia gravis, rheumatoid arthritis, acute disseminated encephalomyelitis, idiopathic thrombocytopenic purpura, multiples sclerosis, Sjoegren's syndrome and autoimmune hemolytic anemia, allergic conditions including all forms of hypersensitivity, The present invention also enables methods for treating cancers that are mediated, dependent on or associated with p110 activity, including but not restricted to leukemias, such as Acute Myeloid leukaemia (AML) Myelo-dysplastic syndrome (MDS) myelo-proliferative diseases (MPD) Chronic Myeloid Leukemia (CML) T-cell Acute Lymphoblastic leukaemia (T-ALL) B-cell Acute Lymphoblastic leukaemia (B-ALL) Non Hodgkins Lymphoma (NHL) B-cell lymphoma and solid tumors, such as breast cancer. | 04-05-2012 |
20120220585 | HETEROCYCLIC COMPOUNDS AND THEIR USES - Substituted bicyclic heteroaryls and compositions containing them, for the treatment of general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, including but not restricted to autoimmune diseases such as systemic lupus erythematosis (SLE), myestenia gravis, rheumatoid arthritis, acute disseminated encephalomyelitis, idiopathic thrombocytopenic purpura, multiples sclerosis, Sjoegren's syndrome and autoimmune hemolytic anemia, allergic conditions including all forms of hypersensitivity, The present invention also enables methods for treating cancers that are mediated, dependent on or associated with p110δ activity, including but not restricted to leukemias, such as Acute Myeloid leukaemia (AML) Myelo-dysplastic syndrome (MDS) myelo-proliferative diseases (MPD) Chronic Myeloid Leukemia (CML) T-cell Acute Lymphoblastic leukaemia (T-ALL) B-cell Acute Lymphoblastic leukaemia (B-ALL) Non Hodgkins Lymphoma (NHL) B-cell lymphoma and solid tumors, such as breast cancer. | 08-30-2012 |
20120220586 | HETEROCYCLIC COMPOUNDS AND THEIR USES - Substituted bicyclic heteroaryls and compositions containing them, for the treatment of general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, including but not restricted to autoimmune diseases such as systemic lupus erythematosis (SLE), myestenia gravis, rheumatoid arthritis, acute disseminated encephalomyelitis, idiopathic thrombocytopenic purpura, multiples sclerosis, Sjoegren's syndrome and autoimmune hemolytic anemia, allergic conditions including all forms of hypersensitivity, The present invention also enables methods for treating cancers that are mediated, dependent on or associated with p110δ activity, including but not restricted to leukemias, such as Acute Myeloid leukaemia (AML) Myelo-dysplastic syndrome (MDS) myelo-proliferative diseases (MPD) Chronic Myeloid Leukemia (CML) T-cell Acute Lymphoblastic leukaemia (T-ALL) B-cell Acute Lymphoblastic leukaemia (B-ALL) Non Hodgkins Lymphoma (NHL) B-cell lymphoma and solid tumors, such as breast cancer. | 08-30-2012 |
20130085131 | HETEROCYCLIC COMPOUNDS AND THEIR USES - Substituted bicyclic heteroaryls and compositions containing them, for the treatment of general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, including but not restricted to autoimmune diseases such as systemic lupus erythematosis (SLE), myestenia gravis, rheumatoid arthritis, acute disseminated encephalomyelitis, idiopathic thrombocytopenic purpura, multiples sclerosis, Sjoegren's syndrome and autoimmune hemolytic anemia, allergic conditions including all forms of hypersensitivity, The present invention also enables methods for treating cancers that are mediated, dependent on or associated with pi 110δ activity, including but not restricted to leukemias, such as Acute Myeloid leukaemia (AML) Myelo-dysplastic syndrome (MDS) myelo-proliferative diseases (MPD) Chronic Myeloid Leukemia (CML) T-cell Acute Lymphoblastic leukaemia (T-ALL) B-cell Acute Lymphoblastic leukaemia (B-ALL) Non Hodgkins Lymphoma (NHL) B-cell lymphoma and solid tumors, such as breast cancer. | 04-04-2013 |
20130267524 | HETEROCYCLIC COMPOUNDS AND THEIR USES - Substituted bicyclic heteroaryls and compositions containing them, for the treatment of general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, including but not restricted to autoimmune diseases such as systemic lupus erythematosis (SLE), myestenia gravis, rheumatoid arthritis, acute disseminated encephalomyelitis, idiopathic thrombocytopenic purpura, multiples sclerosis, Sjoegren's syndrome and autoimmune hemolytic anemia, allergic conditions including all forms of hypersensitivity, The present invention also enables methods for treating cancers that are mediated, dependent on or associated with p110δ activity, including but not restricted to leukemias, such as Acute Myeloid leukaemia (AML) Myelo-dysplastic syndrome (MDS) myelo-proliferative diseases (MPD) Chronic Myeloid Leukemia (CML) T-cell Acute Lymphoblastic leukaemia (T-ALL) B-cell Acute Lymphoblastic leukaemia (B-ALL) Non Hodgkins Lymphoma (NHL) B-cell lymphoma and solid tumors, such as breast cancer. | 10-10-2013 |
20130267526 | HETEROCYCLIC COMPOUNDS AND THEIR USES - Substituted bicyclic heteroaryls and compositions containing them, for the treatment of general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, including but not restricted to autoimmune diseases such as systemic lupus erythematosis (SLE), myestenia gravis, rheumatoid arthritis, acute disseminated encephalomyelitis, idiopathic thrombocytopenic purpura, multiples sclerosis, Sjoegren's syndrome and autoimmune hemolytic anemia, allergic conditions including all forms of hypersensitivity, The present invention also enables methods for treating cancers that are mediated, dependent on or associated with p110 activity, including but not restricted to leukemias, such as Acute Myeloid leukaemia AML) Myelo-dysplastic syndrome (MDS) myelo-proliferative diseases (MPD) Chronic Myeloid Leukemia (CML) T-cell Acute Lymphoblastic leukaemia (T-ALL) B-cell Acute Lymphoblastic leukaemia (B-ALL) Non Hodgkins Lymphoma (NHL) B-cell lymphoma and solid tumors, such as breast cancer. | 10-10-2013 |
20140206694 | HETEROCYCLIC COMPOUNDS AND THEIR USES - Substituted bicyclic heteroaryls and compositions containing them, for the treatment of general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, including but not restricted to autoimmune diseases such as systemic lupus erythematosis (SLE), myestenia gravis, rheumatoid arthritis, acute disseminated encephalomyelitis, idiopathic thrombocytopenic purpura, multiples sclerosis, Sjoegren's syndrome and autoimmune hemolytic anemia, allergic conditions including all forms of hypersensitivity, The present invention also enables methods for treating cancers that are mediated, dependent on or associated with p110δ activity, including but not restricted to leukemias, such as Acute Myeloid leukaemia (AML) Myelo-dysplastic syndrome (MDS) myelo-proliferative diseases (MPD) Chronic Myeloid Leukemia (CML) T-cell Acute Lymphoblastic leukaemia (T-ALL) B-cell Acute Lymphoblastic leukaemia (B-ALL) Non Hodgkins Lymphoma (NHL) B-cell lymphoma and solid tumors, such as breast cancer. | 07-24-2014 |
20150045361 | HETEROCYCLIC COMPOUNDS AND THEIR USES - Substituted bicyclic heteroaryls and compositions containing them, for the treatment of general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, including but not restricted to autoimmune diseases such as systemic lupus erythematosis (SLE), myestenia gravis, rheumatoid arthritis, acute disseminated encephalomyelitis, idiopathic thrombocytopenic purpura, multiples sclerosis, Sjoegren's syndrome and autoimmune hemolytic anemia, allergic conditions including all forms of hypersensitivity, The present invention also enables methods for treating cancers that are mediated, dependent on or associated with p110δ activity, including but not restricted to leukemias, such as Acute Myeloid leukaemia (AML) Myelo-dysplastic syndrome (MDS) myelo-proliferative diseases (MPD) Chronic Myeloid Leukemia (CML) T-cell Acute Lymphoblastic leukaemia (T-ALL) B-cell Acute Lymphoblastic leukaemia (B-ALL) Non Hodgkins Lymphoma (NHL) B-cell lymphoma and solid tumors, such as breast cancer. | 02-12-2015 |
20150266824 | Pyrazole Amide Derivative - The present invention relates to a novel compound having a function of inhibiting RORγ activity. The present invention also relates to pharmaceutical composition comprising the compound, a use of the compound in treating or preventing autoimmune diseases, inflammatory diseases, metabolic diseases, or cancer diseases. | 09-24-2015 |
Xueshi Hao, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20110003798 | COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS - The invention provides a novel class of 2,7-naphthyridin derivatives; pharmaceutical compositions comprising such compounds and methods of using such compounds to treat o prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly Syk, ZAP70, KDR, FMS, FLT*, c-Kit, RET, TrkA, TrkB, TrkC-GR-1R, Alk, c-FMS or combinations thereof. | 01-06-2011 |
20110053897 | COMPOUNDS AND COMPOSITIONS AS SYK KINASE INHIBITORS - Provided herein area novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated Syk kinase activity. | 03-03-2011 |
20110262963 | BIOSYNTHETICALLY GENERATED PYRROLINE-CARBOXY-LYSINE AND SITE SPECIFIC PROTEIN MODIFICATIONS VIA CHEMICAL DERIVATIZATION OF PYRROLINE-CARBOXY-LYSINE AND PYRROLYSINE RESIDUES - Disclosed herein is pyrroline-carboxy-lysine (PCL), a pyrrolysine analogue, which is a natural, biosynthetically generated amino acid, and methods for biosynthetically generating PCL. Also disclosed herein are proteins, polypeptides and peptides that have PCL incorporated therein and methods for incorporating PCL into such proteins, polypeptides and peptides. Also disclosed herein is the site-specific derivatization of proteins, polypeptides and peptides having PCL or pyrrolysine incorporated therein. Also disclosed herein is the crosslinking of proteins, polypeptides and peptides having PCL or pyrrolysine incorporated therein. | 10-27-2011 |
20140302553 | BIOSYNTHETICALLY GENERATED PYRROLINE-CARBOXY-LYSINE AND SITE SPECIFIC PROTEIN MODIFICATIONS VIA CHEMICAL DERIVATIZATION OF PYRROLINE-CARBOXY-LYSINE AND PYRROLYSINE RESIDUES - Disclosed herein is pyrroline-carboxy-lysine (PCL), a pyrrolysine analogue, which is a natural, biosynthetically generated amino acid, and methods for biosynthetically generating PCL. Also disclosed herein are proteins, polypeptides and peptides that have PCL incorporated therein and methods for incorporating PCL into such proteins, polypeptides and peptides. Also disclosed herein is the site-specific derivatization of proteins, polypeptides and peptides having PCL or pyrrolysine incorporated therein. Also disclosed herein is the crosslinking of proteins, polypeptides and peptides having PCL or pyrrolysine incorporated therein. | 10-09-2014 |
Yi-Hsien Hao, Saratoga, CA US
Patent application number | Description | Published |
---|---|---|
20090010160 | Fairness scheme method and apparatus for pause capable and pause incapable ports - A network device, which includes a port, a tag generation unit and a flow control module, is provided. The port, which is connected to a network entity, is configured to send and receive a data packet. The tag generation unit is configured to generate a tag based upon the network entity. The tag generation unit is also configured to add the tag to the data packet and to activate the tag. The flow control module is coupled with a buffer, and is configured to control storage of the data packet into the buffer. The flow control module is also coupled with the port, and is configured to control a communication session conducted between the network device and the network entity based upon the tag. | 01-08-2009 |
Yong Hao, Vancouver, CA US
Patent application number | Description | Published |
---|---|---|
20140350103 | SUSTAINED RELEASE DELIVERY OF ACTIVE AGENTS TO TREAT GLAUCOMA AND OCULAR HYPERTENSION - A method of decreasing intraocular pressure (IOP) in an eye of a patient in need thereof includes implanting a first lacrimal implant through a firsts punctum and into a first lacrimal canaliculus of the eye of the patient. The method may further comprise implanting a second lacrimal implant through a second punctum and into a second lacrimal canaliculus of the eye of the patient, and releasing, on a sustained basis a therapeutically effective amount of an intraocular pressure-reducing therapeutic agent. | 11-27-2014 |
Yong Hao, Pasadena, CA US
Patent application number | Description | Published |
---|---|---|
20150030529 | ISOTHERMAL SYNTHESIS OF FUELS WITH REACTIVE OXIDES - A method for converting thermal energy to chemical energy by reducing a reactive oxide substrate at a constant temperature under a first atmosphere with a lower oxygen partial pressure, and then contacting the reduced oxide at the same temperature with a second atmosphere with a higher oxygen partial pressure, during which oxygen is driven into the reduced oxide by the oxygen chemical potential difference between the two atmospheres, thereby leaving fuel behind, i.e. producing fuel. A method for preparing the reactive oxide substrate by using liquid media as a binder and pore former and heating the mixture of the reactive oxide and the liquid media, thereby forming the reactive oxide substrate. | 01-29-2015 |
Yudong Hao, Fremont, CA US
Patent application number | Description | Published |
---|---|---|
20090276198 | Modeling Conductive Patterns Using An Effective Model - A model of a sample with a periodic or non-periodic pattern of conductive and transparent materials is produced based on the effect that the pattern has on TE polarized incident light. The model of the pattern may include a uniform film of the transparent material and an underlying uniform film of the conductive material. When the pattern has periodicity in two directions, the model may include a uniform film of the transparent material and an underlying portion that based on the physical characteristics of the periodic pattern in the TM polarization direction. When the sample includes an underlying periodic pattern that is orthogonal to the top periodic pattern, the sample may be modeled by modeling the physical characteristics of the top periodic pattern and the effect of the bottom periodic pattern. The model may be stored and used to determine a characteristic of the sample. | 11-05-2009 |